[The effects of preparations that influence the brain monoaminergic systems in pain syndromes].
Danilova
E I
EI
Grafova
V N
VN
Reshetniak
V K
VK
D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001169:Arthritis, Experimental / Q000188:drug therapy / Q000503:physiopathology; D015306:Biogenic Monoamines / Q000502:physiology*; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D051381:Rats; D017982:Receptors, Biogenic Amine / Q000187:drug effects* / Q000502:physiology; D013577:Syndrome
D000700:Analgesics; D000975:Antioxidants; D015306:Biogenic Monoamines; D017982:Receptors, Biogenic Amine
Effekty preparatov, vliiaiushchikh na monoaminergicheskie sistemy mozga, pri bolevykh sindromakh.